Sertraline Hydrochloride
Product Images NDC 53002-3215

2 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sertraline Hydrochloride (NDC 53002-3215). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530023215)

Label Image (Lbl530023215)
Sertraline Hydrochloride 100 mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates the product is for oral use with a typical dose of one tablet daily or as directed. It includes directions, warnings, barcode, and product identification information for 30 tablets per bottle.*
FDA Label Image

Chemical Structure (Sertraline Str)

Chemical Structure (Sertraline Str)
Chemical structure of Sertraline Hydrochloride showing its molecular arrangement, including two chlorine atoms attached to one benzene ring and a secondary amine group with a hydrochloride moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.